Cannabis Law Report

SEPTEMBER 12, 2019

11, 2019 /PRNewswire/ – Aurora Cannabis Inc. the “ Company ” or “ Aurora “) (NYSE | TSX: ACB), the Canadian company defining the future of cannabis worldwide, announced today its financial and operational results for the fourth quarter and fiscal year ended June 30, 2019.

Research and Development 45

Research and Development Extraction Cannabis Wellness and Beauty 45

Cannabis Law Report

MAY 17, 2019

PUBLISHER: CANNABIS LAW REPORT. With the growing number of states legalizing marijuana for medical and recreational use, many brands have emerged for cannabis and related goods and services. For marks used for cannabis products above 0.3% For marks used for cannabis products above 0.3% AUTHOR: Joshua B.

Hemp 63

Hemp THC Sativa Cannabis 63

Cannabis Law Report

DECEMBER 2, 2021

Generally, medicinal cannabis products are only available, on prescription, if they have: been assessed by the Medicinal Cannabis Agency as meeting the minimum quality standard under the Misuse of Drugs (Medicinal Cannabis) Regulations 2019, or. MW Pharma Limited t/a NUBU Pharmaceuticals. CDC Pharmaceuticals Ltd.

Medicine 52

Medicine Pharmaceutical Sativa THC 52

Cannabis Law Report

DECEMBER 19, 2021

17 December 2021: New medicinal cannabis products have been verified as meeting the minimum quality standard – Read more. Medicinal cannabis products that meet the minimum quality standard under the Misuse of Drugs (Medicinal Cannabis) Regulations 2019. MW Pharma Limited t/a NUBU Pharmaceuticals. 4 Oct 2021.

Medicine 52

Medicine Pharmaceutical THC Sativa 52

Canna Law Blog

JULY 2, 2022

On June 14, 2022, Harris Bricken attorneys Fred Rocafort, Jihee Ahn, Paul Coble, and Vincent Silwoski presented a webinar entitled Protecting, Monetizing and Enforcing Cannabis Intellectual Property. In this post, we will answer the cannabis patent questions that were not addressed in the webinar. delta-9-THC).

Extraction 68

Extraction Strains Conditions Cannabis 68

Cannabis Law Report

SEPTEMBER 3, 2019

Construction of New Melbourne-area Extraction Facility on Schedule. Awarded Australian Cannabis Industry 2019 Innovation Award. 03, 2019 (GLOBE NEWSWIRE) — MediPharm Labs Corp. This input supply will support the extraction and production of private label oil in Australia for local and international markets.

Pharmaceutical 45

Pharmaceutical Extraction Research and Development Supply Chain 45

Cannabis Law Report

JUNE 2, 2021

In 2019, the Idaho State Board of Pharmacy issued an advisory document confirming the same. Cannabidiol (CBD) oil is an oil that comes from the cannabis plant, and under Idaho law, is not necessarily considered a controlled substance. Pharmaceutical Grade CBD Oil. 2015 Idaho Att’y Gen. 132, available at [link] (“AG Report”).

Law 103

Law Marijuana Oil Pharmaceutical 103

Veriheal

NOVEMBER 17, 2020

Ohio is currently accepting petitions in an attempt to expand the list of qualifying conditions for medical cannabis. Ohio became the 25th state to legalize medical cannabis back on June 8 of 2016. Medical cannabis is now available to residents in Ohio who meet one of 22 qualifying conditions laid out by House Bill 523.

Conditions 98

Conditions Research and Development Pharmaceutical Clinical Trials 98

MedicalJane

MAY 21, 2020

Researchers at The University of New Mexico (UNM) have conducted a series of recent studies testing the effectiveness and safety of consuming cannabis, but this is the first study they have conducted measuring the therapeutic potential of hemp oil with low THC levels. Hemp” is defined in the Act as “the plant Cannabis sativa L.

Oil 100

Oil Hemp Extraction Clinical Trials 100

Cannabis Law Report

DECEMBER 14, 2019

Investing in cannabis stocks on the ASX: Risks and benefits for ASX pot stocks. Medical cannabis was legalized in Australia in 2016 when the Narcotic Drugs Act was amended, allowing cannabis to be grown for medical and scientific purposes. million in the Melbourne cannabis firm in 2018. Writes Investing News.com.

Pharmaceutical 98

Pharmaceutical Patients Clinical Trials Hemp 98

Cannabis Law Report

NOVEMBER 1, 2021

Traces of banned drugs have been found in nearly 200 imported cannabis-derived wellness products that have been gaining popularity in Hong Kong in recent years, a customs source has told the Post. The substance is allowed in Hong Kong as long as other prohibited ingredients derived from cannabis are not present in the products.

Wellness and Beauty 52

Wellness and Beauty CBD Clinical Trials Pharmaceutical 52

CannaTech

AUGUST 9, 2020

billion in sales in 2020, with 14% growth over 2019 sales of $4.1 Extensive media coverage and natural health and wellness trends: Growing awareness of CBD’s health benefits, combined with a movement toward natural alternatives to pharmaceuticals, is driving consumer demand for CBD products. unemployment in rate in June, up from 3.8%

Wellness and Beauty 52

Wellness and Beauty CBD Pets Extraction 52

Cannabis Law Report

APRIL 26, 2022

Known for its harsh anti-drug policies, Thailand became the first country in South East Asia to legalise medical cannabis in 2018, with the legislation passing in February 2019. However, cannabis extracts with a concentration of tetrahydrocannabinol (commonly referred to as ‘THC’ and the compound that gives a high) of more than 0.2%

Legislation 52

Legislation Agriculture Research and Development Banking 52

Canna Law Blog

MARCH 12, 2019

In keeping with last week’s cannabis patent litigation update , it’s important to discuss a landmark decision that was made by the U.S. Patent and Trademark Office (“USPTO”) Patent Trial and Appeal Board (“PTAB”) on claims involving a cannabis patent just two months ago. GW Pharma”) and Otsuka Pharmaceuticals Co.,

Epilepsy 71

Epilepsy Pharmaceutical Cannabinoids CBD 71

Canna Law Blog

NOVEMBER 14, 2021

In recent times, many trademark applications filed by cannabis businesses have been refused on lawful-use grounds, though this legal prohibition can manifest itself in more mundane ways. Mind Medicine, also known as MindMed, filed an application to register the MINDMED mark in 2019. This is a question that often comes up, given U.S.

Pharmaceutical 72

Pharmaceutical Treatment Edibles Medicine 72

SpeedWeed

AUGUST 1, 2021

announced on July 30 that the company’s CW Labs science division and Colorado State University’s (CSU) College of Agricultural Sciences have completed the first of three collaborative metabolomic hemp studies to decode the complex chemical profile of full spectrum hemp extracts—made from the company’s patented hemp cultivars. .

Hemp 52

Hemp Extraction Agriculture Strains 52

Cannabis Law Report

JUNE 19, 2019

Hepatotoxicity of a Cannabidiol-Rich Cannabis Extract in the Mouse Model. Department of Pharmaceutics and Drug Delivery, School of Pharmacy, University of Mississippi, University, MS 38677, USA. Department of Pharmaceutical Sciences, University of Arkansas for Medical Sciences, Little Rock, AR 72223, USA. *. Skinner, C.M.;

CBD 40

CBD Research and Development Extraction Pharmaceutical 40

Cannabis Law Report

OCTOBER 9, 2019

07, 2019 (GLOBE NEWSWIRE) — MediPharm Labs Corp. Pat McCutcheon, CEO of MediPharm Labs, will participate on a panel discussion that will provide an update on key medical cannabis markets in Europe. MediPharm Labs will be presenting alongside management representatives from Aurora Cannabis Inc. TORONTO, Oct.

Hemp 40

Hemp Extraction Events Cannabinoids 40

Cannabis Law Report

FEBRUARY 5, 2020

Aurora’s River production facility in Bradford, Ontario, has received European Union Good Manufacturing Practice certification, the cannabis company announced on Monday. The EU GMP certification is required to export medical cannabis products into most European markets.

Pharmaceutical 59

Pharmaceutical Extraction Cannabis Compliance 59

Cannabis Law Report

JANUARY 5, 2020

I känik Farms is close to being able to bring its California good vibes to global cannabis markets. This week, Ikänik announced its Latin American subsidiary, Pideka, received good agricultural and collection practice from the Colombian government for its Casa Flores cannabis camp. Image courtesy of Ikänik Farms.

Cultivation 59

Cultivation Pharmaceutical Cannabis Agriculture 59

Cannabis Law Report

JANUARY 13, 2020

We previously explored the applicability of trade secret protection to cannabis-related inventions. Here, we provide an overview of patent trends in the cannabis industry and how cannabusinesses can use patents to protect their technological, agricultural, genetic, or other innovations. The Power of a Patent.

Extraction 59

Extraction Collective Supply Chain Strains 59

Cannabis Law Report

SEPTEMBER 28, 2019

It also liberalizes 99%-pure CBD oil made from hemp (scientific name: Cannabis sativa L. What it means in a layman’s term is that 99%-pure CBD oil made from cannabis or hemp with a mix of very little psychoactive THC is no longer a narcotic under the Narcotics Act of 1979. Foreign Investments in Local Cannabis Production.

Oil 58

Oil Media Law Extraction 58

Cannabis Law Report

AUGUST 30, 2021

Kratom is the extract from the Mitragyna speciosa tree native to Southeast Asia and is popular in the region for its therapeutic effects. Statistics show that there are 5 million avid kratom consumers in the USA by 2019. The botanical herb gained entry into the USA about a decade ago and gradually gained popularity.

Business 101

Business Education Media Pharmaceutical 101

CannaTech

AUGUST 9, 2020

billion in sales in 2020, with 14% growth over 2019 sales of $4.1 Extensive media coverage and natural health and wellness trends: Growing awareness of CBD’s health benefits, combined with a movement toward natural alternatives to pharmaceuticals, is driving consumer demand for CBD products. unemployment rate in June, up from 3.8%

CBD 52

CBD Wellness and Beauty Extraction Retail 52

Cannabis Law Report

JULY 22, 2019

million common shares of Supreme Cannabis (the “Consideration Shares”), giving the Transaction an approximate dollar value of $20,000,000 as of the Company’s closing price on July 16, 2019. The Transaction is valued at 14.7 ” Transaction Highlights.

Legalization 40

Legalization Research and Development Extraction Pharmaceutical 40

Cannabis Law Report

JANUARY 17, 2022

EXI retroactively adopted the International Financial Reporting Standard effective July 1, 2019 and so the financial statements restated for IFRS for the years ended June 30, 2021 and June 30, 2020 and as at July 1, 2019 have also been posted. Extraction wages and supplies. Write-off of mobile extraction lab. 274,866. .

Extraction 52

Extraction Pharmaceutical Programs Business 52

The Cannigma

MARCH 7, 2022

Yet cannabinol (CBN), the first cannabinoid ever discovered by modern scientists, is slowly making a comeback in the cannabis industry. . Of course, this plant is now known to be marijuana (or Type I cannabis), which is still commonly used for sleep and analgesia today. The best online schools for medical cannabis training.

THC 140

THC Sleep Clinical Trials Cannabinoids 140

Cannabis Law Report

JUNE 15, 2021

. (“PharmaCielo” or the “Company”) (TSXV: PCLO ) (OTCQX: PCLOF), the Canadian parent of Colombia’s premier cultivator and producer of medicinal-grade cannabis extracts, PharmaCielo Colombia Holdings S.A.S., and Canada. ” About PharmaCielo. Forward-Looking Statements.

Research and Development 66

Research and Development Supply Chain Extraction Events 66

Cannabis Law Report

NOVEMBER 22, 2019

Anvisa and Brazilian House of Representatives yield to social pressure and move towards to the universalization of cannabis for medical purposes. As scientific evidence advances on the therapeutic benefits of medicinal products made from Cannabis sp. extracts, the number of countries with specific regulations also increases.

Sativa 59

Sativa Medicine Legalization Epilepsy 59

WeedAdvisor

AUGUST 20, 2019

On July 25 th , 2019, Canada-based PharmaCielo’s Colombian subsidiary, PharmaCielo Colombia S.A.S., This ground-breaking achievement marked a huge milestone for the South American cannabis industry and an even bigger one on a global scale. PharmaCielo’s shipment represents a huge leap forward in cannabis reform.

CBD 45

CBD Research and Development Pharmaceutical Extraction 45

The Cannigma

MAY 9, 2021

If you live in Colorado, the emissions produced growing the weed an average Coloradan cannabis user consumes in a year is equivalent to 60% of the total household carbon imprint, according to a recent report. Four times the energy as the pharmaceutical industry. pharmaceutical industry energy expenditure. But there’s a price.

Agriculture 144

Agriculture Cultivation Wellness and Beauty Consumption 144

Cannabis Law Report

JULY 11, 2019

9 July 2019, London. EMMAC Life Sciences Ltd, the European independent medical cannabis company, is pleased to announce that it has formed a 50/50 joint venture company, Fontana S.R.L. as Farmalabor’s dedicated cannabis partner. Fontana JVCo”), with Sergio Fontana, the founder and major shareholder of Farmalabor S.R.L.

Access 40

Access Supply Chain Research and Development Pharmaceutical 40

Canna Law Blog

MARCH 12, 2020

In fact, our team of hemp lawyers just led a pretty awesome webinar on the international cannabis market, which you can watch for free here. EIHA argued that there is a difference between hemp extracts and isolates, and that it was correct to note that foods containing isolated CBD were indeed novel. that the CBD craze is global.

Hemp 61

Hemp CBD Food Extraction 61

Cannabis Law Report

JANUARY 27, 2020

after alleging the pot producer failed to pay for millions of dollars’ worth of cannabis oil over a supply deal signed last year, the marijuana extraction company said in a court filing. MediPharm issued a press release on Friday stating its wholly-owned subsidiary filed a lawsuit against an unnamed cannabis producer for $9.8

Extraction 71

Extraction Events Oil Pharmaceutical 71

Cannabis Law Report

NOVEMBER 27, 2019

COLORADO SPRINGS, CO / ACCESSWIRE / November 27, 2019 / Folium Biosciences (Folium), the world’s largest vertically integrated producer, manufacturer, and distributor of Broad-Spectrum Hemp-derived Cannabinoids, launches “Truth in Hemp ” our industry facing platform and commitment in support of further reasonable regulation.

Hemp 59

Hemp Cannabinoids Supply Chain Pharmaceutical 59

Cannabis Law Report

JUNE 14, 2019

The production or commercialization of the marijuana plant (cannabis spp.) In Brazil is prohibited. Anvisa only authorizes the importation of plants in cases of research or for the pharmaceutical industry. Is there a production of cannabis-based medicine and its derivatives in Brazil? How does it work today in Brazil?

Medicine 40

Medicine Pharmaceutical Environment Cultivation 40

Veriheal

AUGUST 31, 2020

Most of the conventional methods for treating migraines involve pharmaceutical medication, which has been known to be accompanied by unwanted side effects, especially from opioid based medication. Participants in the study used an application called “Releaf Application” in order to record the details of their cannabis use.

Treatment 98

Treatment Consumption Indica Hybrid 98